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1,2 HCV screening in an outpatient endoscopy setting presents an opportunity for HCV screening, given that most patients referred for screening colonoscopy are within the 1945 to 1965 birth cohort for which HCV testing is recommended. The rationale for HCV screening during endoscopy is 3-fold: (1) safety-net primary care providers may not have time to address HCV risk factors; (2) the 1945 to 1965 birth cohort is within recommendations for colon cancer screening; and (3) HCV screening and diagnosis in endoscopy settings may have improved linkage-to-care into gastroenterology clinics. We aimed to evaluate the effectiveness of a pilot model implementing HCV screening into outpatient endoscopy including both birth cohort-and risk factor-based screening.
Methods
We prospectively evaluated all adults presenting for outpatient endoscopy from July 1, 2015, to July 1, 2016, at an urban safety-net hospital. Patients were screened for HCV testing eligibility using US Preventative Services Task Force guidelines. Among eligible patients, HCV antibody (Ab) testing was offered. Patients with positive HCV antibody were recommended for confirmatory HCV RNA testing. Confirmed chronic HCV patients were scheduled into the HCV clinic. Predictors of HCV Ab completion among those offered testing were evaluated with multivariate logistic regression models. Variables selected for inclusion included sex a priori in addition to variables that showed significance in the univariate model (P < .10). The final model adjusted for sex, race/ethnicity, country of birth, and language spoken. Statistical analyses were performed using Stata statistical package (version 13, Stata Corporations, College Station, TX) and statistical significance was met with a 2-tailed P value less than .05. This study was approved by the Institutional Review Board at Alameda Health System.
Results
Among 1125 patients (52.3% women; mean age, 52.4 y; SD, 12.3 y; 87.6% non-white minority; 4.3% history of intravenous drug use; 12.5% history of incarceration; 6.5% human immunodeficiency virus positive; and 59.7% born between 1945 and 1965), we found 66.5% (748 of 1125) were eligible for HCV screening, among which 30.9% (231 of 748) had received prior testing. A total of 84.2% (502 of 748) of patients who were offered HCV screening accepted. Of the 502 who accepted HCV Ab testing, 318 (63.7%) completed the test: 81.1% completed on the same day and 94.7% within 1 week, with no difference between birth cohort-and risk factor-based patients. Nonsignificant lower proportions of HCV test completion were seen in non-English speaking vs English speaking patients (odds ratio, 0.53; 95% CI, 0.27-1.05; P ¼ .06). Fourteen (4.4%) patients had positive HCV Ab, of whom 11 completed confirmatory testing with HCV RNA. Five patients had negative RNA and 6 patients had confirmed HCV infection. All 6 patients were linked into the HCV clinic ( Figure 1 ).
Discussion
Previous studies have shown suboptimal screening rates at the primary care level. 1, [3] [4] [5] Efforts to improve HCV screening include best practice alert prompts as well as focused HCV screening in emergency departments to improve HCV screening. 4, 6 Endoscopy units provide a unique opportunity for HCV screening, given the aforementioned reasons. Sears et al 7 offered HCV screening to patients age 50 to 65 years undergoing outpatient colonoscopy. Among 500 patients offered, 376 (75.2%) accepted, with 4 patients positive for HCV antibody, and 1 confirmed case of chronic HCV. Our pilot program, which focused on both birth cohort-and risk factor-based screening, showed similar outcomes, improving HCV Ab completion from 30.9% to 63.6% among at-risk individuals offered screening.
Although HCV screening is important, linkage-to-care remains challenging, with 32% to 38% of all HCV patients receiving follow-up care and 13% receiving treatment. 8 In our cohort, all 6 confirmed chronic HCV patients were linked to care, but 3 patients with positive HCV Ab did not complete RNA testing. Although we show improved HCV screening, patients presenting for routine endoscopy are more engaged in care. Thus, although our results are encouraging among safety-net populations, they may not be completely generalizable to more vulnerable populations with significant barriers in access to care. 2 Although it is important to note that test completion results could be improved with same-day HCV Ab testing, reflexive HCV RNA testing for positive HCV Ab was implemented in January 2017.
Despite recent improvements in HCV screening, overall HCV screening and linkage to care remains suboptimal. Our pilot model of integrating HCV screening into outpatient endoscopy units provides a feasible and effective option that narrows the gap in HCV screening, particularly among at-risk safety-net populations.
